Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 94, Issue 1, Pages 55-61
Publisher
Wiley
Online
2018-10-08
DOI
10.1002/ajh.25308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
- (2018) Yutaka Niihara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults
- (2017) Sherif M. Badawy et al. Health and Quality of Life Outcomes
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
- (2017) Kenneth I. Ataga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sickle Cell Disease
- (2017) Frédéric B. Piel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology
- (2016) D. Zhang et al. BLOOD
- Minireview: Genetic basis of heterogeneity and severity in sickle cell disease
- (2016) Alawi Habara et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia
- (2015) N. Lemonne et al. HAEMATOLOGICA
- Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia
- (2015) N. Lemonne et al. HAEMATOLOGICA
- Cellular Adhesion and the Endothelium
- (2014) Abdullah Kutlar et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
- (2013) D. Manwani et al. BLOOD
- Hydroxyurea in Sickle Cell Disease: Drug Review
- (2013) Rohit Kumar Agrawal et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Sickle cell pain: a critical reappraisal
- (2012) S. K. Ballas et al. BLOOD
- Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?
- (2011) Patrick T McGann et al. CURRENT OPINION IN HEMATOLOGY
- Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease
- (2010) D. R. Gutsaeva et al. BLOOD
- How I use hydroxyurea to treat young patients with sickle cell anemia
- (2010) R. E. Ware BLOOD
- Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities
- (2010) Amanda M Brandow et al. Expert Review of Hematology
- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
- (2009) Matthew M. Hsieh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paucity of HLA-Identical Unrelated Donors for African-Americans with Hematologic Malignancies: The Need for New Donor Options
- (2008) Alexander Dew et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The vessel wall and its interactions
- (2008) D. D. Wagner et al. BLOOD
- Hydroxyurea for the Treatment of Sickle Cell Anemia
- (2008) Orah S. Platt NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started